In the BH3 profiling, we exposed eight cases of human MLL-ALL cells to BH3 sensitizer peptides NOXA, HRK and BAD as well as pro-apoptotic activator peptide, BIM. Here, HRK is linked to acute lymphoblastic leukemia.